Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06817174

Ovarian Cancer Radiomics Approach in CT Led Evaluation

Prospective Validation of CT Based Radiomic Models to Predict Surgical and Clinical Outcomes in Advanced Epithelial Ovarian Cancer

Status
Recruiting
Phase
Study type
Observational
Enrollment
168 (estimated)
Sponsor
Imperial College Healthcare NHS Trust · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

When patients have suspected or confirmed ovarian cancer standard treatment will involve surgery and chemotherapy. However, as with any treatment, it is challenging to predict treatment response in advance. Before treatment, all patients have a CT scan to describe where the cancer is in order to guide the treatment. There is now a new way to analyse routine scans using advanced computing methods, which may give more information about the ovarian cancer. This is called radiomics which analyses features in scans that are not visible to the naked eye. Our group at Imperial College London has worked on developing radiomic models to better understand ovarian cancer. This study aims to determine whether the information gained from this new approach would help us to tailor patient treatment plans to better meet the patient's individual needs, even more than done already. Furthermore, the aim is to understand how different types of ovarian cancer can correlate with the radiomic findings, which may help develop potential treatments in the future.

Conditions

Timeline

Start date
2025-02-10
Primary completion
2032-01-01
Completion
2032-01-01
First posted
2025-02-10
Last updated
2025-06-27

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06817174. Inclusion in this directory is not an endorsement.